HACOR Score for NIV Failure Risk
Heart rate, Acidosis, Consciousness, Oxygenation and Respiratory rate (HACOR) predicts failure of non-invasive ventilation (need for intubation) in hypoxaemic patients, assessed after 1 hour of NIV (Duan 2017: 449 patients, validated in 358). At 1 h, a score > 5 predicted failure with sensitivity 72.6% and specificity 90.2%.
Score interpretation
HACOR ≤ 5 after 1 hour of NIV — NIV likely to succeed; keep reassessing.
→ Continue NIV and optimise settings, mask fit and synchrony; reassess HACOR and blood gases; keep an airway plan available.
HACOR > 5 after 1 hour of NIV — high risk of NIV failure; in Duan 2017, intubation within 12 h was associated with lower hospital mortality than later intubation.
→ Senior ICU / anaesthetic review; plan early controlled intubation unless a ceiling of treatment applies; document the decision and treat the underlying cause.
Interpretation bands for the HACOR Score. Apply clinical judgement and local guidance.
References
- Duan J, Han X, Bai L, Zhou L, Huang S. Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Med. 2017;43(2):192–199.
- Scala R, Pisani L. Noninvasive ventilation in acute respiratory failure: which recipe for success? Eur Respir Rev. 2018;27(149):180029.
Related
Curated clinical cross-links plus same-class fallbacks.
- Dobutamine (Acute HF / Stress Echo) · Inotrope / Acute Heart Failure
- Milrinone · Inodilator / Acute Heart Failure
- Mannitol (Osmotic Diuretic — Renal/Neurological) · Acute Oliguric Renal Failure / Raised ICP
- Doxapram hydrochloride · Respiratory stimulant
- Glyceryl Trinitrate (Sublingual / IV) · Nitrate / Acute Angina
- Vericiguat · Heart Failure
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.